Skip to main content

Subsite Title

Publications and Digital Products

Cart

Store Navigation

Share Buttons

Page title

Medications to Treat Opioid Use During Pregnancy – An info sheet for providers

Main page content

Download only

This information sheet, for practitioners, explains the importance of concurrent treatment of OUD with prenatal/postpartum care and the importance of providing the materials to clients. 

Publication ID
SMA19-5094-IS
Publication Date
April 2019
Last Reviewed
April 2019
Format

You May Also Be Interested In

Rx Pain Medications, Know the Options, Get the Facts: Treating Overdose with Naloxone

The Rx Pain Medications. Know the Options. Get the Facts. is a series of 13 fact sheets designed to increase awareness of the risks associated with prescription opioid use and misuse, as well as to educate patients who are prescribed opioids for pain about the risks and to provide resources on methods for alternative pain management. This particular fact sheet focuses on using Naloxone as a deterrent to overdose.

Healthy Pregnancy Healthy Baby Fact Sheets

This series of four fact sheets emphasizes the importance of continuing a mother's treatment for opioid use disorder (OUD) throughout pregnancy. The series includes information on OUD and pregnancy, OUD treatment, neonatal abstinence syndrome, and considerations to address before hospital discharge.

Talk. They Hear You: Coach Your Kids Through More Than Just Homework Print Public Service Announcement – Wallet Card

This wallet card is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging parents to talk with their kids about opioids.

This item comes in packs of 50.

Talk. They Hear You: Before She’s Too Cool for Mom to Drop Her Off at School Print Public Service Announcement – Wallet Card

This wallet card is related to the public service announcement from SAMHSA's “Talk. They Hear You.” campaign encouraging parents to talk with their kids about opioids.

This item comes in packs of 50.

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

Behavioral Health Barometer: United States, 2013

This report presents a set of substance use and mental health indicators from population and treatment facility-based data sets. It provides point-in-time and trend data reflecting the status and progress of improving key behavioral health indicators.